3P BIOTECH NORWAY AS: årsregnskap 2019 vs 2018
Grew 203% on revenue
approved 2020-04-30; registry 2020-10-06; journal 2020 919188
Summary
What changed
Comparing Årsregnskap 2019 with 2018 for 3P BIOTECH NORWAY AS. Revenue 26.6k NOK → 80.7k NOK (+203.2%). Equity 382.3k NOK → 393.2k NOK.
On the constructive side: revenue rose; operating result improved; equity strengthened. Pressures included: cash fell.
Also worth watching: cogs moved. All figures are taken from the published annual accounts for 3P BIOTECH NORWAY AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 26.6k NOK to 80.7k NOK (+203.2% YoY). Calculated
-
↑
Operating result improved
Operating result +8 740 NOK → +18.3k NOK (op. margin 32.9% → 22.6%). Calculated
-
↑
Equity strengthened
Book equity 382.3k NOK → 393.2k NOK (equity ratio 23.4% → 16.9%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 476.2k NOK → 487.1k NOK (+10.9k NOK). Reported fact
What deteriorated
-
↓
Cash fell
Bank deposits 11.6k NOK → 6 409 NOK (-44.8% YoY). Calculated
Things to notice
-
·
COGS moved
COGS / varekostnad 15.6k NOK → 32.1k NOK (+105.0% YoY). Calculated